Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women’s health.
The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets. Well-known brands associated with Perrigo include ACO, Compeed, Mederma and HRA Pharma’s women’s health products. In the United States, Perrigo markets Opill, a progestin-only oral contraceptive that became the first daily birth-control pill available over the counter in the country.
Perrigo traces its origins to 1887, when it began as a small retail business in Allegan, Michigan. It has since expanded through product development and acquisitions, with operations and commercial activities serving consumers primarily in North America and Europe, as well as selected international markets. Perrigo Company plc is incorporated in Ireland and is led by President and Chief Executive Officer Patrick Lockwood-Taylor.
AI Generated. May Contain Errors.
